Lemonis indicated expectations for continued growth over the Q1 base in Q3, with similar or slightly higher order count but potentially lower average order value as patio sales mix out. He stated, “we ...
Quantum BioPharma Ltd. announced its plan to issue a special dividend in the form of Contingent Value Rights (CVRs) to holders of its Class B Subordinate Voting Shares, on a 1:1 basis. Each CVR will ...
IGM Biosciences, Inc. has announced a definitive merger agreement with Concentra Biosciences, LLC, under which Concentra will acquire IGM for $1.247 in cash per share of common stock, along with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results